Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
Many CEPA compliance risks arise from overlooked operational obligations. Learn which reporting, recordkeeping, and notification duties companies often underestimate.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
The CoRAP (Community Rolling Action Plan) is a collaborative EU initiative for prioritizing and evaluating chemical substances over three years. It aims to assess potential hazards and manage risks, with evaluations influencing regulatory decisions for safer industrial practices.
At the dawn of the publication of the REACH report (scheduled for 2017 by the Commission), debates on chemical regulation are intensifying. NGOs and national agencies oppose companies that want to defend their economic interests. EcoMundo decodes for you the challenges of substituting chemical substances and the Commission's strategy for a non-toxic environment.
The European Commission is opening a consultation until 28 January 2017 on the evaluation of the REACH regulation as part of the Refit program to review the quality of European legislation in force. The aim of this consultation? Gather the views of stakeholders on the approach to this assessment as well as on the strengths and weaknesses of the current regulations in preparation for their next revision.
The FDA banned 19 active substances in antibacterial soaps due to lack of safety and effectiveness data. Consumers are advised to use plain soap and water instead. Some producers have already removed the banned substances from their products.
The European cosmetics industry is highly regulated to ensure consumer safety, with claims on products needing to meet six criteria under regulation 655/2013. Authorities monitor compliance, focusing on truthfulness and fairness, to prevent misleading marketing.
The European market lacks investment in SVHC substitution, hindering progress. The Lowell centre recommends building infrastructures, increasing engagement, and enhancing technical capacity to support the analysis of alternatives. Authorities face challenges in identifying, evaluating, and adopting SVHC substitution. ECHA can play a key role in supporting these initiatives. For more information on SVHCs, visit our website.
